Clinicopathological and prognostic significance of programmed cell death ligand 1 expression in patients diagnosed with breast cancer: meta-analysis

BACKGROUND: Uncertainty exists regarding the clinical relevance of programmed cell death ligand 1 (PD-L1) expression in breast cancer. METHODS: A systematic review was performed in accordance with PRISMA guidelines. Observational studies that compared high versus low expression of PD-L1 on breast ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Davey, M G, Ryan, É J, Davey, M S, Lowery, A J, Miller, N, Kerin, M J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Systematic Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364926/
https://www.ncbi.nlm.nih.gov/pubmed/33963374
http://dx.doi.org/10.1093/bjs/znab103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10364926/
https://www.ncbi.nlm.nih.gov/pubmed/33963374
http://dx.doi.org/10.1093/bjs/znab103

Ejemplares similares